UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN)
CUSIP: M96088105
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Ordinary Shares, par value NIS 0.01 per share
- Shares outstanding
- 48,684,257
- Total 13F shares
- 43,904,765
- Share change
- +3,965,252
- Total reported value
- $877,180,169
- Put/Call ratio
- 27%
- Price per share
- $19.95
- Number of holders
- 159
- Value change
- +$94,297,658
- Number of buys
- 80
- Number of sells
- 67
Quarterly Holders Quick Answers
What is CUSIP M96088105?
CUSIP M96088105 identifies URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP M96088105:
Top shareholders of URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13F
|
Company |
9.3%
|
4,543,895
|
$62,251,362 | — | 30 Jun 2025 | |
| TORONTO DOMINION BANK |
13F
|
Company |
6.6%
|
3,190,510
|
$43,709,987 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13D/G
13F
|
Company |
5.4%
|
2,488,299
|
$35,433,378 | +$24,712,637 | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
4.9%
|
2,405,241
|
$32,951,802 | — | 30 Jun 2025 | |
| Soleus Capital Master Fund, L.P. |
13D/G
|
— |
4.7%
|
2,185,000
|
$31,114,400 | -$1,993,600 | 30 Jun 2025 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
4.5%
|
2,199,652
|
$30,135,232 | — | 30 Jun 2025 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
4.5%
|
2,185,000
|
$29,934,500 | — | 30 Jun 2025 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
4.2%
|
2,022,482
|
$27,708,003 | — | 30 Jun 2025 | |
| Ran Nussbaum |
3/4/5
|
Director |
—
class O/S missing
|
1,485,168
|
$26,747,876 | — | 21 Oct 2022 | |
| MENORA MIVTACHIM HOLDINGS LTD. |
13D/G
13F
|
Company |
5%
|
2,303,031
|
$24,780,614 | $0 | 11 Mar 2025 | |
| ACORN CAPITAL ADVISORS, LLC |
13F
|
Company |
2.6%
|
1,259,749
|
$17,258,560 | — | 30 Jun 2025 | |
| SG Americas Securities, LLC |
13F
|
Company |
2.4%
|
1,149,081
|
$15,742,000 | — | 30 Jun 2025 | |
| Adage Capital Management, L.P. |
13D/G
|
— |
2.8%
|
1,277,000
|
$13,740,520 | -$17,765,685 | 31 Mar 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.1%
|
1,000,000
|
$13,700,000 | — | 30 Jun 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.7%
|
830,000
|
$11,371,000 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.7%
|
807,638
|
$11,064,641 | — | 30 Jun 2025 | |
| Migdal Insurance & Financial Holdings Ltd. |
13F
|
Company |
1.6%
|
770,909
|
$10,561,000 | — | 30 Jun 2025 | |
| Kynam Capital Management, LP |
13F
|
Company |
1.3%
|
656,573
|
$8,995,050 | — | 30 Jun 2025 | |
| Monograph Capital Holdings Advisors, LLC |
13D/G
|
Monograph Capital Partners I, L.P. |
1.8%
|
838,615
|
$8,503,556 | $0 | 05 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.2%
|
594,031
|
$8,138,225 | — | 30 Jun 2025 | |
| Boxer Capital Management, LLC |
13F
|
Company |
1.2%
|
575,000
|
$7,877,500 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.1%
|
543,196
|
$7,441,785 | — | 30 Jun 2025 | |
| Rosalind Advisors, Inc. |
13F
|
Company |
1.1%
|
542,366
|
$7,430,414 | — | 30 Jun 2025 | |
| Wildcat Capital Management, LLC |
13F
|
Company |
1%
|
495,606
|
$6,789,802 | — | 30 Jun 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
1%
|
484,823
|
$6,642,075 | — | 30 Jun 2025 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.98%
|
478,400
|
$6,554,080 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.97%
|
470,726
|
$6,448,946 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.8%
|
390,364
|
$5,347,987 | — | 30 Jun 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.79%
|
384,891
|
$5,273,007 | — | 30 Jun 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.74%
|
361,441
|
$4,953,000 | — | 30 Jun 2025 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.72%
|
349,515
|
$4,788,356 | — | 30 Jun 2025 | |
| Walleye Capital LLC |
13F
|
Company |
0.71%
|
346,162
|
$4,742,419 | — | 30 Jun 2025 | |
| Atom Investors LP |
13F
|
Company |
0.65%
|
317,596
|
$4,351,065 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.63%
|
308,527
|
$4,226,820 | — | 30 Jun 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.63%
|
306,724
|
$4,202,119 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.6%
|
290,577
|
$3,980,905 | — | 30 Jun 2025 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.59%
|
287,874
|
$3,943,874 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.55%
|
267,718
|
$3,667,738 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.54%
|
265,117
|
$3,632,103 | — | 30 Jun 2025 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.54%
|
261,785
|
$3,586,454 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.52%
|
254,971
|
$3,493,103 | — | 30 Jun 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.48%
|
231,574
|
$3,172,564 | — | 30 Jun 2025 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.45%
|
218,837
|
$2,998,074 | — | 30 Jun 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.45%
|
218,500
|
$2,993,448 | — | 30 Jun 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.39%
|
189,412
|
$2,594,944 | — | 30 Jun 2025 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.38%
|
185,030
|
$2,534,000 | — | 30 Jun 2025 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.36%
|
176,702
|
$2,420,817 | — | 30 Jun 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.35%
|
168,779
|
$2,312,268 | — | 30 Jun 2025 | |
| ARK Investment Management LLC |
13F
|
Company |
0.34%
|
166,094
|
$2,275,488 | — | 30 Jun 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.32%
|
158,052
|
$2,165,312 | — | 30 Jun 2025 |
Institutional Holders of UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN) as of Q3 2025
As of 30 Sep 2025,
UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN) was held by
159 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
43,904,765 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, Paradigm Biocapital Advisors LP, TORONTO DOMINION BANK, BlackRock, Inc., MORGAN STANLEY, Jefferies Financial Group Inc., SILVERARC CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, ACORN CAPITAL ADVISORS, LLC, and SG Americas Securities, LLC.
This page lists
159
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
149
Q3 2025 holders
159
Holder diff
10
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.